TGFB1 and Bloom syndrome: In comparison with expression in mice in the control group, the expression of TGF-β1 in both BALF and serum was significantly increased in mice following BLM intervention, and QRHXF or PFD treatment significantly reduced this level (Fig. 5a, b).